News & Updates

An article (Hebrew) written by @Yuval Horn, @Roy Ribon and @Assaf Unger of Horn & Co., with respect to legal aspects of blockchain assets and cryptocurrency offerings, published on @themarker.

January 29, 2018

Yuval Horn, Paz Abercohen and Uri Dotan of Horn & Co. represented IOptima Ltd. and its shareholders, including Biolight Life Sciences Investments Ltd (TASE: BOLT) in a multi-stage acquisition transaction with an aggregate deal value of up to approximately $50 million, with Chengdu Kanghong Pharmaceutical Group, a Chinese life sciences company listed on the Shenzhen stock exchange.

November 28, 2017

Yuval Horn, Keren Kanir and Uri Dotan of Horn & Co. represented Vascular Biogenics Ltd. (Nasdaq: VBLT) in its $18.75 Million follow-on offering on NASDAQ.

November 26, 2017

Yuval Horn and Paz Abercohen of Horn & Co. acted as Israeli counsel to Protalix BioTherapeutics, Inc. (NYSE: PLX) in a $9 Million private notes exchange agreement, and a $10 Million private placement of the company’s Secured Convertible Notes.

July 27, 2017

Horn & Co. ranked, again, by iam Magazine (Intellectual Asset Management) as one of top 3 “highly recommended” Israeli firms in the field of intellectual property transactions

June 13, 2017

Yuval Horn, Keren Kanir, Ohad Mamann and Tammy Alon of Horn & Co., Law Offices represented Eloxx Pharmaceuticals Ltd. in its Series C financing round and simultaneous entering into an agreement for an acquisition transaction with Sevion Therapeutics, Inc.

June 4, 2017

Adv. Yuval Horn participated in the 5th Annual World Life Sciences Conference

June 1, 2017

Horn & Co. has been recognized by Legal 500 as a “Tier 1” firm in Israel in the field of Healthcare and Life Sciences. Yuval Horn was noted as a Tier I practitioner. Legal 500 notes: “the firm has been active at the ‘top level’ in the healthcare sector for over 20 years”

April 23, 2017

Yuval Horn, Roy Ribon and Yasmin Zohar of Horn & Co. acted as Israeli counsel to Therapix Biosciences Ltd. (NASDAQ: TRPX) (TASE: THXBY), in its listing on Nasdaq and offering of $12 million

March 23, 2017

Horn & Co. once again recognized as one of the elite law firms in Israel by Dun & Bradstreet, in its 2017 ranking by fields of expertise

March 17, 2017